Tilray Brands Inc(TLRY) Price Forecast & Company Analysis. P/E · Dividend · Earnings · Price Target · RSI · MACD | US Stocks Today
Oct 28 at 6:10 PM ET (Korea 10/29 07:10)
Full metrics table
| Index | - | P/E | - | EPS (ttm) | -1.4 | Insider Own | 1.59% | Shs Outstand | 147.8M | Perf Week | -7.88% |
| Market Cap | 0.40B | Forward P/E | - | EPS next Y | 63.43% | Insider Trans | 0.64% | Shs Float | 145.4M | Perf Month | -31.9% |
| Enterprise Value | 0.53B | PEG | - | EPS next Q | -0.16 | Inst Own | 9.75% | Short Float | 14.8% | Perf Quarter | -35.95% |
| Income | -0.16B | P/S | 0.41 | EPS this Y | 48.39% | Inst Trans | 2.94% | Short Ratio | 5.12 | Perf Half Y | -56.19% |
| Sales | 0.96B | P/B | 0.24 | EPS next 5Y | 67.72% | ROA | -7.45% | Short Interest | 21.52M | Perf YTD | -70.21% |
| Book/sh | 11.29 | P/C | 1.8 | EPS past 3/5Y | 64.12% 39.71% | ROE | -10.38% | 52W High | -82.87% ($15.70) | Perf Year | -80.51% |
| Cash/sh | 1.5 | P/FCF | - | Sales past 3/5Y | 13.44% 12.28% | ROIC | -8.64% | 52W Low | 0.37% ($2.68) | Perf 3Y | -84.27% |
| Dividend Est. | - | EV/EBITDA | 52.25 | EPS Y/Y TTM | 93.85% | Gross Margin | 26.82% | Volatility(W/M) | 4.8% 5.1% | Perf 5Y | -97.44% |
| Dividend TTM | - | EV/Sales | 0.55 | Sales Y/Y TTM | 15.93% | Oper. Margin | -6.28% | ATR (14) | 0.16 | Perf 10Y | - |
| Dividend Ex-Date | - | Quick Ratio | 1.11 | EPS Q/Q | -10683.33% | Profit Margin | -17.05% | RSI (14) | 21.22 | Recom | 2.4 |
| Dividend Gr. 3/5Y | - | Current Ratio | 1.88 | Sales Q/Q | 22.74% | SMA20 | -16.52% ($3.22) | Beta | 2.01 | Target Price | $5.61 |
| Payout | - | Debt/Eq | 0.23 | Earnings | 2026/10/8 | SMA50 | -30.6% ($3.88) | Rel Volume | 1.03 | Prev Close | $2.77 |
| Employees | 3595 | LT Debt/Eq | 0.17 | EPS/Sales Surpr. | -76.41% -3.42% | SMA200 | -51.46% ($5.54) | Avg Volume(3M) | 4.20M | Price | $2.69 |
| IPO | 2018/7/19 | Option/Short | Yes/Yes | Trades | 7566 | Volume | 4,332,028 | Change | -2.89% |
🌿 Tilray Brands (TLRY) is a global consumer products company positioned at the intersection of the beverage, cannabis, and wellness industries. It is a leading player in Canada's adult-use and medical cannabis markets and operates a diversified brand portfolio that spans European medical cannabis, North American hemp wellness, and U.S. craft beer businesses.
Over the past 1 year, on the lower side
83% below its 1-year high.
Traded about as much as usual. That is 103% of its average volume.
TLRY has a sound balance sheet but weak earning power
Of every $100 in sales, $6.28 is lost.
Tap to view numbers
Earnings are growing steadily
Earnings are expected to grow by +48.4% this year.
Tap to view numbers
Relative to sales, it looks cheap
Loss-making, so we compare on sales. For a company selling $100 a year, you would pay $41. Peers typically go for $154.
Tap to view numbers
Results have missed expectations
Frequently misses analyst estimates
Tap to view numbers
Opinions on the outlook are split
Analyst sentiment is Buy.
Tap to view numbers
Holding long would have lost money
Bought 5 years ago, your return today would be -97.4%. The S&P 500 did +69% over the same period.
Tap to view numbers
No dividend
There is no profit to distribute yet.
Institutions barely hold it
Institutions hold 9.8%.
Tap to view numbers
Multiple ETFs hold this stock, but only a sliver
Buying this ETF gives you exposure to this stock as well.
It ranks #42 of 83 in the industry
Based on market cap of $398M.
EOLS#39 Evolus Inc $504M PER - 
KMDA#40 Kamada Ltd $462M PER 21.0 
TKNO#41 Alpha Teknova Inc $422M PER - TLRY#42 Tilray Brands Inc $398M PER - 
EBS#43 Emergent Biosolutions Inc $364M PER - 
FAQ
What kind of company is TLRY?
TLRY belongs to the Healthcare sector and operates in the Drug Manufacturers - Specialty & Generic industry.
What is the market cap of TLRY?
The market cap of TLRY is approximately $398M, ranking 3,349 within its sector.
What is the 52-week high and low for TLRY?
TLRY has recorded a 52-week high of $15.70 and a low of $2.68.
